Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) affect 17–46% of Western countries, making coexistence with other liver diseases inevitable. We investigated the prevalence and clinical significance of NAFLD/NASH or the components of metabolic syndrome...

Full description

Bibliographic Details

Published in:	JHEP Reports
Main Authors:	Kalliopi Zachou, Kalliopi Azariadis, Ellina Lytvyak, Romée J.A.L.M. Snijders, Atsushi Takahashi, Nikolaos K. Gatselis, Mercedes Robles, Raul J. Andrade, Christoph Schramm, Ansgar W. Lohse, Atsushi Tanaka, Joost P.H. Drenth, Aldo J. Montano-Loza, George N. Dalekos
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Subjects:	Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Metabolic dysfunction-associated fatty liver disease Autoimmune hepatitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S258955592300109X